Immunogenicity and efficacy in hemodialysis patients of an AS03A-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial

Background - Hemodialysis patients have a reduced response to vaccinations because of uremia-related immune dysfunction. To increase the immunogenicity of vaccines, antigens can be formulated with adjuvants. The new tocopherol-containing adjuvant system AS03A has not been tested yet in patients with...

Full description

Saved in:
Bibliographic Details
Main Authors: Dikow, Ralf (Author) , Eckerle, Isabella (Author) , Ksoll-Rudek, Dorothea (Author) , Hampel, Heidrun (Author) , Schwenger, Vedat (Author) , Zeier, Martin (Author) , Schnitzler, Paul (Author) , Sommerer, Claudia (Author)
Format: Article (Journal)
Language:English
Published: February 24, 2011
In: American journal of kidney diseases
Year: 2011, Volume: 57, Issue: 5, Pages: 716-723
ISSN:1523-6838
DOI:10.1053/j.ajkd.2010.11.031
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1053/j.ajkd.2010.11.031
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0272638611000461
Get full text
Author Notes:Ralf Dikow, Isabella Eckerle, Dorothea Ksoll-Rudek, Heidrun Hampel, Vedat Schwenger, Martin Zeier, Paul Schnitzler, and Claudia Sommerer

MARC

LEADER 00000caa a2200000 c 4500
001 1806841169
003 DE-627
005 20230427160803.0
007 cr uuu---uuuuu
008 220613s2011 xx |||||o 00| ||eng c
024 7 |a 10.1053/j.ajkd.2010.11.031  |2 doi 
035 |a (DE-627)1806841169 
035 |a (DE-599)KXP1806841169 
035 |a (OCoLC)1341461337 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Dikow, Ralf  |d 1973-  |e VerfasserIn  |0 (DE-588)12216217X  |0 (DE-627)705795497  |0 (DE-576)293125899  |4 aut 
245 1 0 |a Immunogenicity and efficacy in hemodialysis patients of an AS03A-adjuvanted vaccine for 2009 pandemic influenza A(H1N1)  |b a nonrandomized trial  |c Ralf Dikow, Isabella Eckerle, Dorothea Ksoll-Rudek, Heidrun Hampel, Vedat Schwenger, Martin Zeier, Paul Schnitzler, and Claudia Sommerer 
264 1 |c February 24, 2011 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Im Titel ist "A" bei "AS03" tiefgestellt 
500 |a Gesehen am 13.06.2022 
520 |a Background - Hemodialysis patients have a reduced response to vaccinations because of uremia-related immune dysfunction. To increase the immunogenicity of vaccines, antigens can be formulated with adjuvants. The new tocopherol-containing adjuvant system AS03A has not been tested yet in patients with end-stage renal disease. - Study Design - Nonrandomized trial. - Setting & Participants - 291 hemodialysis patients from 3 dialysis units co-operating with the Department of Nephrology at the University Hospital Heidelberg, Germany: 169 patients were vaccinated using either 1 (64 patients) or 2 doses (105 patients); 123 patients refused the vaccination and served as controls. - Intervention - Intramuscular immunization with 3.75 μg of an inactivated split-virion A/California/7/2009 H1N1v pandemic vaccine adjuvanted with AS03A in a single- or double-dose regimen. - Outcomes - A pandemic influenza A immunoglobulin G (IgG) enzyme-linked immunosorbent assay (ELISA) response >11 AU (arbitrary units) was defined as a positive response. - Measurements - Quantitative antibody testing using the pandemic influenza A IgG ELISA. Antibody titers were tested 3 months after vaccination and compared with nonimmunized dialysis patients. - Results - After vaccination against 2009 pandemic influenza A(H1N1), 41 of 64 (64.1%) patients with 1 vaccination and 93 of 105 (88.6%) with 2 vaccinations showed a protective immune response compared with 43 of 123 (34.9%) unvaccinated patients (P < 0.001). Logistic regression analysis confirmed vaccination dose as an independent factor for response to pandemic H1N1 vaccination. No episode of pandemic H1N1 illness occurred in any group within the study period of 6 months after vaccination. No serious adverse events occurred, and local symptoms ranged from mild to moderate in 143 of 169 (84.6%) patients. - Limitations - Nonrandomized assignment; use of nontreated patients as controls; no comparison to nonadjuvanted vaccines; dose variation in the intervention group. - Conclusions - Pandemic H1N1 vaccine adjuvanted with AS03A is immunogenic, effective, and safe in hemodialysis patients. 
650 4 |a Adjuvant 
650 4 |a dialysis 
650 4 |a end-stage renal disease 
650 4 |a immunogenicity 
650 4 |a influenza A(H1N1) 
650 4 |a influenza vaccination 
700 1 |a Eckerle, Isabella  |e VerfasserIn  |4 aut 
700 1 |a Ksoll-Rudek, Dorothea  |e VerfasserIn  |4 aut 
700 1 |a Hampel, Heidrun  |e VerfasserIn  |4 aut 
700 1 |a Schwenger, Vedat  |e VerfasserIn  |0 (DE-588)1022867652  |0 (DE-627)717320197  |0 (DE-576)176592237  |4 aut 
700 1 |a Zeier, Martin  |e VerfasserIn  |0 (DE-588)1026480302  |0 (DE-627)726772356  |0 (DE-576)371826438  |4 aut 
700 1 |a Schnitzler, Paul  |d 1959-  |e VerfasserIn  |0 (DE-588)1022905643  |0 (DE-627)717329798  |0 (DE-576)366155695  |4 aut 
700 1 |a Sommerer, Claudia  |d 1971-  |e VerfasserIn  |0 (DE-588)121857654  |0 (DE-627)705680002  |0 (DE-576)292921829  |4 aut 
773 0 8 |i Enthalten in  |t American journal of kidney diseases  |d Philadelphia, Pa. : Elsevier Saunders, 1981  |g 57(2011), 5, Seite 716-723  |h Online-Ressource  |w (DE-627)320593169  |w (DE-600)2019205-8  |w (DE-576)091138760  |x 1523-6838  |7 nnas  |a Immunogenicity and efficacy in hemodialysis patients of an AS03A-adjuvanted vaccine for 2009 pandemic influenza A(H1N1) a nonrandomized trial 
773 1 8 |g volume:57  |g year:2011  |g number:5  |g pages:716-723  |g extent:8  |a Immunogenicity and efficacy in hemodialysis patients of an AS03A-adjuvanted vaccine for 2009 pandemic influenza A(H1N1) a nonrandomized trial 
856 4 0 |u https://doi.org/10.1053/j.ajkd.2010.11.031  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0272638611000461  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220613 
993 |a Article 
994 |a 2011 
998 |g 121857654  |a Sommerer, Claudia  |m 121857654:Sommerer, Claudia  |d 50000  |e 50000PS121857654  |k 0/50000/  |p 8  |y j 
998 |g 1022905643  |a Schnitzler, Paul  |m 1022905643:Schnitzler, Paul  |d 910000  |d 911700  |d 50000  |e 910000PS1022905643  |e 911700PS1022905643  |e 50000PS1022905643  |k 0/910000/  |k 1/910000/911700/  |k 0/50000/  |p 7 
998 |g 1026480302  |a Zeier, Martin  |m 1026480302:Zeier, Martin  |d 910000  |d 910100  |d 50000  |e 910000PZ1026480302  |e 910100PZ1026480302  |e 50000PZ1026480302  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 6 
998 |g 1022867652  |a Schwenger, Vedat  |m 1022867652:Schwenger, Vedat  |d 50000  |e 50000PS1022867652  |k 0/50000/  |p 5 
998 |g 12216217X  |a Dikow, Ralf  |m 12216217X:Dikow, Ralf  |d 50000  |e 50000PD12216217X  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1806841169  |e 4148799829 
BIB |a Y 
SER |a journal 
JSO |a {"id":{"eki":["1806841169"],"doi":["10.1053/j.ajkd.2010.11.031"]},"origin":[{"dateIssuedDisp":"February 24, 2011","dateIssuedKey":"2011"}],"name":{"displayForm":["Ralf Dikow, Isabella Eckerle, Dorothea Ksoll-Rudek, Heidrun Hampel, Vedat Schwenger, Martin Zeier, Paul Schnitzler, and Claudia Sommerer"]},"recId":"1806841169","person":[{"given":"Ralf","role":"aut","family":"Dikow","display":"Dikow, Ralf"},{"family":"Eckerle","given":"Isabella","role":"aut","display":"Eckerle, Isabella"},{"display":"Ksoll-Rudek, Dorothea","role":"aut","given":"Dorothea","family":"Ksoll-Rudek"},{"display":"Hampel, Heidrun","role":"aut","given":"Heidrun","family":"Hampel"},{"display":"Schwenger, Vedat","family":"Schwenger","given":"Vedat","role":"aut"},{"display":"Zeier, Martin","given":"Martin","role":"aut","family":"Zeier"},{"role":"aut","given":"Paul","family":"Schnitzler","display":"Schnitzler, Paul"},{"display":"Sommerer, Claudia","family":"Sommerer","role":"aut","given":"Claudia"}],"title":[{"title_sort":"Immunogenicity and efficacy in hemodialysis patients of an AS03A-adjuvanted vaccine for 2009 pandemic influenza A(H1N1)","subtitle":"a nonrandomized trial","title":"Immunogenicity and efficacy in hemodialysis patients of an AS03A-adjuvanted vaccine for 2009 pandemic influenza A(H1N1)"}],"physDesc":[{"extent":"8 S."}],"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"relHost":[{"disp":"Immunogenicity and efficacy in hemodialysis patients of an AS03A-adjuvanted vaccine for 2009 pandemic influenza A(H1N1) a nonrandomized trialAmerican journal of kidney diseases","recId":"320593169","part":{"extent":"8","text":"57(2011), 5, Seite 716-723","volume":"57","pages":"716-723","issue":"5","year":"2011"},"id":{"eki":["320593169"],"issn":["1523-6838"],"zdb":["2019205-8"]},"origin":[{"publisher":"Elsevier Saunders","dateIssuedKey":"1981","dateIssuedDisp":"1981-","publisherPlace":"Philadelphia, Pa."}],"language":["eng"],"pubHistory":["1.1981 -"],"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"corporate":[{"display":"National Kidney Foundation","role":"isb"}],"titleAlt":[{"title":"AJKD"}],"title":[{"title":"American journal of kidney diseases","subtitle":"AJKD ; official journal of the National Kidney Foundation","title_sort":"American journal of kidney diseases"}]}],"note":["Im Titel ist \"A\" bei \"AS03\" tiefgestellt","Gesehen am 13.06.2022"]} 
SRT |a DIKOWRALFEIMMUNOGENI2420